InMode (INMD) Asset Writedowns and Impairment (2018 - 2023)
InMode (INMD) posted quarterly Asset Writedowns and Impairment of $355000.0 for Q4 2023, up 655.32% year-on-year from $47000.0 in Q4 2022, and down 16.67% on a QoQ basis from $426000.0 in Q3 2023.
InMode (INMD) Asset Writedowns and Impairment (2018 - 2023) Analysis & Trends
InMode (INMD) has reported Asset Writedowns and Impairment for 6 consecutive years, with $355000.0 the latest figure, recorded in Q4 2023.
- Quarterly Asset Writedowns and Impairment rose 655.32% year-over-year to $355000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.1 million (up 142.54% YoY) and the FY2025 annual result came in at $454000.0, down 20.63% from the prior year.
- Asset Writedowns and Impairment declined to $355000.0 in Q4 2023 per INMD's latest filing, from $426000.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for INMD reached as high as $426000.0 in Q3 2023 and fell as low as -$55000.0 in Q4 2019.
- A 5-year average of $140388.9 and a median of $100000.0 in 2019 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2019 — Asset Writedowns and Impairment plunged 650.0% — and 2023, when it surged 752.0%.
- Year by year, Asset Writedowns and Impairment stood at -$55000.0 in 2019, then surged by 56.36% to -$24000.0 in 2020, then soared by 687.5% to $141000.0 in 2021, then tumbled by 66.67% to $47000.0 in 2022, then jumped by 655.32% to $355000.0 in 2023.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $355000.0, $426000.0, and $261000.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn |
| 10 | InMode | 974,410.00 | -479.15 Mn | 61.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 355,000.00 |
| Dec 31, 2023 | 355,000.00 |
| Sep 30, 2023 | 426,000.00 |
| Sep 30, 2023 | 426,000.00 |
| Jun 30, 2023 | 261,000.00 |
| Jun 30, 2023 | 261,000.00 |
| Dec 31, 2022 | 47,000.00 |
| Dec 31, 2022 | 47,000.00 |
| Sep 30, 2022 | 50,000.00 |
| Sep 30, 2022 | 50,000.00 |
| Jun 30, 2022 | 142,000.00 |
| Jun 30, 2022 | 142,000.00 |
| Mar 31, 2022 | 210,000.00 |
| Mar 31, 2022 | 210,000.00 |
| Dec 31, 2021 | 141,000.00 |
| Dec 31, 2021 | 141,000.00 |
| Sep 30, 2021 | 48,000.00 |
| Sep 30, 2021 | 48,000.00 |
| Jun 30, 2021 | 287,000.00 |
| Jun 30, 2021 | 287,000.00 |